ibusinesslines.com
ibusinesslines.com July 20, 2018


Health Canada recalls some drugs containing valsartan due to potential carcinogen

13 July 2018, 09:54 | Melissa Porter

Valsartan a common heart disease drug is being recalled across Europe because it contains a chemical that has the potential to cause cancer

Valsartan a common heart disease drug is being recalled across Europe because it contains a chemical that has the potential to cause cancer

Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world because of its chemical ingredient possibly linking to cancer.

The valsartan was supplied by Zhejiang Huahai Pharmaceuticals.

The alert comes after the watchdog issued a recall last week (July 6) for seven batches of valsartan-containing medicines made by Accord Healthcare and Dexcel Pharma Ltd, after an impurity was identified in their manufacturing process which "may have carcinogenic potential".

The announcement follows news last week that the European Medicines Agency launched a recall and review of valsartan-containing drugs. The report of withdrawal includes shipments, withdrawal quantity and other evidence of withdrawal at wholesalers, retailers and users who have purchased drugs according to the regulations of the Ministry of Health.


Valsartan is an angiotensin-II-receptor antagonist used to treat hypertension (high blood pressure), recent heart attack and heart failure.

As a precautionary measure, the valsartan-containing medications are recalled on a pharmacy level. "The pharmacist can then figure out alternative medications that are unaffected by the recall".

Health Canada says that if you find out the drug you are taking contains the ingredient to continue taking it for now and to contact your health care practitioner as soon as possible to discuss your treatment options.

Mina Tadrous, (pharmacy faculty, University of Toronto), explained that valsartan is a common drug used by people with high blood pressure. Andre specializes in environmental health, but writes on a variety of issues.



Other News

Trending Now

Eden Hazard to Real Madrid: Playing for Los Blancos is everyone's dream
Hazard is said to be interested in working with the Blaugrana and the club's coaching staff are already excited by the prospect. Catalan giants, Barcelona are preparing a move for Eden Hazard with Chelsea owner Roman Abramovich open to selling the Belgian.

Fiat staff to strike over Cristiano Ronaldo’s £88 million Juventus move
As captain of the Portuguese team in the 2018 World Cup, he scored four goals , including a hat-trick against Spain. That holding company, Exor , owns 64 per cent of Juventus , and 30 per cent of Fiat Chrysler Automobiles (FCA).

Backlash over Forbes dubbing Kylie Jenner 'self-made'
Privileged or self-made? Kylie Jenner is set to beat Facebook founder Mark Zuckerberg as the "Youngest Self-Made Billionaire". Dictionary.com wants to let Kylie Jenner and Forbes know the meaning behind the word "self-made".

Manchester United set to launch huge bid for England defender
After their title success, City are now striving to win the Champions League and that ambition was of huge appeal to Mahrez. Now we have to work and see what can happen". "It's a good thing".

North Atlantic Treaty Organisation turns its focus on Afghanistan after Trump's harsh criticism day before
Speaking after what he called a "substantive meeting", Mr Stoltenberg acknowledged the day's conversations had included "disagreements".

Nets Trade Jeremy Lin to the Hawks
The Coney Island native averaged 6.3 points and 1.3 assists in 16 games last season, spending much of the year in the G League. Lin missed essentially all of last season for Brooklyn after tearing his ACL in the season-opener against the Pacers.

Canada 'caught in the crossfire' of US-China trade dispute
The first round of tariffs covered Chinese products ranging from farming plows to machine tools and communications satellites. China said it is "shocked" after the USA announced plans for fresh tariffs, escalating a trade war between the two countries.